Trials / Conditions / Stage IV Cutaneous Melanoma
Stage IV Cutaneous Melanoma
4 registered clinical trials studyying Stage IV Cutaneous Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting NCT05079113 | Case Comprehensive Cancer Center | — |
| Completed | Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies NCT03590054 | Rahul Aggarwal | Phase 1 |
| Completed | Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma NCT03396952 | University of California, San Francisco | Phase 2 |
| Terminated | Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV NCT02587650 | University of California, San Francisco | Phase 2 |